Dr Shilpa Gupta from the Taussig Cancer Institute in Cleveland, Ohio, and Prof Thomas Powles from the Barts Cancer Institute in London, United Kingdom, discuss clinical decision-making with numerous treatment strategies for urothelial bladder c
Dr Manish Patel from the Florida Cancer Specialists & Research Institute in Sarasota, Florida, discusses drug development, early-phase clinical trials and the emerging field of B7-H3-targeted antibody-drug conjugates for solid tumors.
Dr Andrew J Armstrong from the Duke Cancer Institute Center in Durham, North Carolina and Dr Maha Hussain from Robert H Lurie Comprehensive Cancer Center in Chicago summarize recent data sets from 2023 on hormonal therapies and other emerging t
Drs Petros Grivas, Vadim S Koshkin, Kriti Mittal, Mamta Parikh and Scott T Tagawa discuss available and emerging research, patient cases from participating junior clinical investigators and the perspectives of senior clinical investigator facul
Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-s
Dr Rana McKay from UC San Diego Moores Cancer Center in La Jolla, California discusses key presentations on genitourinary cancers from the 2023 ASCO Annual Meeting.
Featuring a roundtable discussion on the current and future role of PARP inhibitor-based therapy in the management of prostate cancer, with Drs Neeraj Agarwal, Emmanuel Antonarakis, Susan Slovin, and Prof Karim Fizazi, moderated by Dr Neil Love
Dr Terence Friedlander from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Professor Petros Grivas from the Fred Hutchinson Cancer Research Center in Seattle, Washington, discuss available and novel t
Dr Matthew Galsky from The Tisch Cancer Institute in New York, New York, discusses recent updates from ASCO 2023 on the management of urothelial bladder cancer, moderated by Dr Neil Love.
Proceedings from a webinar held in partnership with the 2023 ONS Congress. Featuring a discussion on the management of urothelial bladder cancer with Ms Brenda Martone and Dr Jonathan E Rosenberg, moderated by Dr Neil Love.
Proceedings from our Year in Review webinar on the management of renal cell carcinoma and bladder cancer. Featuring perspectives from Dr Matthew Milowsky and Prof Thomas Powles, moderated by Dr Neil Love.
Proceedings from our Year in Review webinar on the management of prostate cancer. Featuring perspectives from Drs Tanya Dorff and A Oliver Sartor, moderated by Dr Neil Love.
Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourina
Featuring a discussion on optimizing the use of hormonal therapy in the management of prostate cancer with Prof Karim Fizazi and Prof Stéphane Oudard, moderated by Dr Neil Love.
Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in prostate and bladder cancers. Featuring perspectives from Drs Alicia Morgans and
Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in renal cell carcinoma. Featuring perspectives from Prof Thomas Powles, moderated b
Featuring a discussion on optimizing the use of hormonal therapy in the management of prostate cancer with Dr Matthew Smith, moderated by Dr Neil Love.
Featuring a discussion on current management and novel therapies for nonmetastatic urothelial bladder cancer with Prof Sia Daneshmand, moderated by Dr Neil Love.